Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. While Abbott Laboratories saw sales fall in the first ...

ABBOTT PARK, Ill., Oct. 19, 2011 /PRNewswire/ -- Today Abbott (NYSE: ABT) announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in ...

Abbott Laboratories on Wednesday announced closure of its $25 billion acquisition of St. Jude Medical. St. Jude Medical, based in Little Canada, will become a wholly-owned subsidiary of Abbott and its ...

(AP) -- Abbott Laboratories will spend $25 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's stake in cardiovascular care. Shares of North ...

ABBOTT PARK, Ill., Abbott today announced that it has entered into an agreement to purchase Topera, Inc., a private, venture-backed medical device company focused on developing innovative ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Abbott Laboratories released no new details Wednesday about integration timelines and personnel changes in Minnesota as it completed its long-planned acquisition of Little Canada-based medical device ...

Robert Ford, who has deep experience with the medical device business at Abbott Laboratories, will become the new CEO of the Illinois-based company in March when Chief Executive Miles White steps down ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Abbott (ABT) is a stock that can certainly grab the attention of many investors, but ...